Analyst Reco. Privia Health Group, Inc.

Equities

PRVA

US74276R1023

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
17.15 ^USD	-1.94%		-1.27%	-25.53%

May. 30	Baird Starts Privia Health Group With Outperform Rating, $23 Price Target	MT
May. 20	Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Baird Starts Privia Health Group With Outperform Rating, $23 Price Target	May. 30	MT
Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating	May. 20	MT
Truist Securities Adjusts Price Target on Privia Health Group to $24 From $28, Keeps Buy Rating	May. 15	MT
UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating	May. 10	MT
Citigroup Starts Privia Health Group With Buy Rating, $25 Price Target	Apr. 22	MT
Canaccord Genuity Adjusts Privia Health Group Price Target to $37 From $41, Maintains Buy Rating	Mar. 19	MT
JPMorgan Cuts Price Target on Privia Health to $30 From $38, Maintains Overweight Rating	Mar. 06	MT
Barclays Starts Coverage on Privia Health With Equalweight Rating, $22 Price Target	Mar. 06	MT
UBS Adjusts Privia Health Group Price Target to $29 From $31, Maintains Buy Rating	Mar. 01	MT
TD Cowen Adjusts Price Target on Privia Health to $26 From $30, Maintains Outperform Rating	Mar. 01	MT
Truist Securities Cuts Price Target on Privia Health Group to $28 From $32, Maintains Buy Rating	Feb. 29	MT
RBC Trims Price Target on Privia Health Group to $28 From $32, Keeps Outperform Rating	Feb. 16	MT
JMP Securities Initiates Privia Health Group With Market Outperform Rating, Price Target is $27	Dec. 06	MT
JPMorgan Cuts Privia Health Group's Price Target to $38 From $43, Keeps Overweight Rating	Nov. 17	MT
UBS Trims Privia Health Group Price Target to $31 From $32, Maintains Buy Rating	Nov. 07	MT
RBC Cuts Price Target on Privia Health Group to $32 From $36, Keeps Outperform Rating	Nov. 06	MT
UBS Adjusts Privia Health Price Target to $32 From $35, Maintains Buy Rating	23-08-18	MT
TD Cowen Adjusts Price Target on Privia Health to $35 From $44, Maintains Outperform Rating	23-08-15	MT
Evercore ISI Group Initiates Privia Health Group at Outperform With $34 Price Target	23-06-13	MT
UBS Adjusts Privia Health Price Target to $35 From $30, Maintains Buy Rating	23-05-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Privia Health Group, Inc.

Equities

PRVA

US74276R1023

Analyst Reco.

Filters